Ryan Zimmerman
Stock Analyst at BTIG
(3.60)
# 838
Out of 5,239 analysts
261
Total ratings
46.72%
Success rate
6.89%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUMA Humacyte | Maintains: Buy | $3 → $2 | $1.13 | +76.99% | 10 | May 13, 2026 | |
| ALC Alcon | Maintains: Buy | $87 → $82 | $63.29 | +29.56% | 16 | May 6, 2026 | |
| CARL Carlsmed | Reiterates: Buy | $23 | $10.10 | +127.72% | 3 | May 6, 2026 | |
| SOLV Solventum | Reiterates: Buy | $89 | $74.16 | +20.01% | 4 | May 6, 2026 | |
| TCMD Tactile Systems Technology | Maintains: Buy | $38 → $40 | $23.24 | +72.12% | 7 | May 5, 2026 | |
| KIDS OrthoPediatrics | Reiterates: Buy | $24 | $17.99 | +33.41% | 12 | May 1, 2026 | |
| SYK Stryker | Maintains: Buy | $397 → $379 | $301.18 | +25.84% | 21 | May 1, 2026 | |
| GKOS Glaukos | Maintains: Buy | $131 → $141 | $136.87 | +3.02% | 18 | Apr 30, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $85 → $80 | $62.19 | +28.64% | 9 | Apr 29, 2026 | |
| ISRG Intuitive Surgical | Reiterates: Buy | $574 | $433.09 | +32.54% | 25 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.5 → $1 | $0.48 | +108.42% | 4 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.59 | +208.88% | 12 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $2.06 | +45.99% | 4 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $83.28 | - | 12 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $5.87 | +70.36% | 2 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $24 | $13.51 | +77.65% | 2 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $43 | $25.65 | +67.64% | 2 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $349 | $322.63 | +8.17% | 21 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $4.37 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.52 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $113.99 | +71.07% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $32.60 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $27.40 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $83.61 | +77.01% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.67 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $76.22 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $14.60 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $29.40 | +80.27% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $12.22 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $178.46 | +12.07% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $149.01 | +134.88% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $76.10 | +68.20% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $16.27 | +158.14% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $6.19 | +748.83% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $40.52 | - | 3 | Apr 2, 2020 |
Humacyte
May 13, 2026
Maintains: Buy
Price Target: $3 → $2
Current: $1.13
Upside: +76.99%
Alcon
May 6, 2026
Maintains: Buy
Price Target: $87 → $82
Current: $63.29
Upside: +29.56%
Carlsmed
May 6, 2026
Reiterates: Buy
Price Target: $23
Current: $10.10
Upside: +127.72%
Solventum
May 6, 2026
Reiterates: Buy
Price Target: $89
Current: $74.16
Upside: +20.01%
Tactile Systems Technology
May 5, 2026
Maintains: Buy
Price Target: $38 → $40
Current: $23.24
Upside: +72.12%
OrthoPediatrics
May 1, 2026
Reiterates: Buy
Price Target: $24
Current: $17.99
Upside: +33.41%
Stryker
May 1, 2026
Maintains: Buy
Price Target: $397 → $379
Current: $301.18
Upside: +25.84%
Glaukos
Apr 30, 2026
Maintains: Buy
Price Target: $131 → $141
Current: $136.87
Upside: +3.02%
GE HealthCare Technologies
Apr 29, 2026
Maintains: Buy
Price Target: $85 → $80
Current: $62.19
Upside: +28.64%
Intuitive Surgical
Apr 22, 2026
Reiterates: Buy
Price Target: $574
Current: $433.09
Upside: +32.54%
Mar 31, 2026
Maintains: Buy
Price Target: $1.5 → $1
Current: $0.48
Upside: +108.42%
Mar 26, 2026
Reiterates: Buy
Price Target: $8
Current: $2.59
Upside: +208.88%
Mar 25, 2026
Reiterates: Buy
Price Target: $3
Current: $2.06
Upside: +45.99%
Mar 23, 2026
Downgrades: Neutral
Price Target: n/a
Current: $83.28
Upside: -
Mar 18, 2026
Upgrades: Buy
Price Target: $10
Current: $5.87
Upside: +70.36%
Mar 11, 2026
Maintains: Buy
Price Target: $23 → $24
Current: $13.51
Upside: +77.65%
Feb 26, 2026
Maintains: Buy
Price Target: $41 → $43
Current: $25.65
Upside: +67.64%
Jan 16, 2026
Downgrades: Neutral
Price Target: $349
Current: $322.63
Upside: +8.17%
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $4.37
Upside: -
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.52
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $113.99
Upside: +71.07%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $32.60
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $27.40
Upside: -
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $83.61
Upside: +77.01%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $5.67
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $76.22
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $14.60
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $29.40
Upside: +80.27%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $12.22
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $178.46
Upside: +12.07%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $149.01
Upside: +134.88%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $76.10
Upside: +68.20%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $16.27
Upside: +158.14%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $6.19
Upside: +748.83%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $40.52
Upside: -